Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Operating Expenses (2023 - 2025)

Historic Operating Expenses for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $3.7 million.

  • SeaStar Medical Holding's Operating Expenses fell 1715.3% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year decrease of 818.41%. This contributed to the annual value of $18.0 million for FY2024, which is 2650.95% up from last year.
  • Per SeaStar Medical Holding's latest filing, its Operating Expenses stood at $3.7 million for Q3 2025, which was down 1715.3% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Operating Expenses registered a high of $4.8 million during Q4 2024, and its lowest value of $2.1 million during Q2 2025.
  • For the 3-year period, SeaStar Medical Holding's Operating Expenses averaged around $3.8 million, with its median value being $4.0 million (2024).
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 6458.97% in 2024, then plummeted by 5572.93% in 2025.
  • SeaStar Medical Holding's Operating Expenses (Quarter) stood at $2.9 million in 2023, then soared by 64.59% to $4.8 million in 2024, then decreased by 22.47% to $3.7 million in 2025.
  • Its Operating Expenses was $3.7 million in Q3 2025, compared to $2.1 million in Q2 2025 and $4.1 million in Q1 2025.